| RS2067185063 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067185505 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS2067185564 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067186077 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2067186293 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067186632 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS2067186762 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067186801 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067187127 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS2067187364 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067187424 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067187550 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067187618 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067187668 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067188031 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067188111 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS2067188114 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067188361 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067188459 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067188667 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067188951 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067189266 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067189436 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067189705 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067189853 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067190364 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067190922 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067190976 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067191154 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS2067191335 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067191541 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067191635 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067192032 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067193056 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067193155 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS2067193335 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067193414 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067193558 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067193671 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067193761 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067193857 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS2067194538 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067194648 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067194747 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067194816 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067194846 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067195486 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067195581 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067196140 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067196699 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS2067196800 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067197219 |
CASK
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2067197487 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS2067198376 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067199347 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa |
| RS2067200470 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067201139 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067201253 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS2067202860 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067203546 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067211703 |
TCTN1
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Meckel-Gruber syndrome |
| RS2067215010 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, RPGR-related retinopathy |
| RS2067216516 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS2067217104 |
ITPA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS2067217398 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067217662 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, RPGR-related retinopathy |
| RS2067217874 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067218363 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067221066 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, RPGR-related retinopathy |
| RS2067258421 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS2067265104 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067267431 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067268275 |
JAG1
|
Health Risk |
Pathogenic |
Tetralogy of Fallot, Alagille syndrome due to a JAG1 point mutation |
| RS2067268487 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067270959 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067273607 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067274453 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067277129 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067278577 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mucopolysaccharidosis |
| RS2067278631 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067293664 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Ovarian serous cystadenocarcinoma |
| RS2067296758 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067297301 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067300184 |
JAG1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067301859 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067320699 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067321711 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067324506 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS2067325167 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067328461 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067336398 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067337118 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067339335 |
EXOC7
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and brain atrophy, Neurodevelopmental disorder with seizures and brain atrophy |
| RS2067342745 |
RPS6KA3
|
Health Risk |
Likely pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS2067343280 |
RPS6KA3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 19 |
| RS2067346904 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067347395 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067347502 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067370892 |
ITPA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS2067371776 |
ATRX
|
Health Risk |
Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |